Management of Locally Unresectable Rectal Cancer
Reference125 articles.
1. Gastrointestinal Tumor Study Group. Prolongation of the disease-free interval in surgically treated rectal carcinoma. N. Engl. J. Med., 312 (1985) 1465–1472.
2. Gastrointestinal Tumor Study Group. Adjuvant therapy of colon cancer: results of a prospectively randomized trial. N. Engl. J. Med., 310 (1984) 737–743.
3. Krook JE, Moertel CG, Gunderson LL, Wieand HS, Collins RT, Beart RW, etal. Effective surgical adjuvant therapy for high-risk rectal carcinoma. N. Engl. J. Med., 324 (1991) 709–715.
4. Wolmark N, Weiand HS, Hyams DM, Colangelo L, Dimitrov N, Romond EH, etal. Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project protocol R-02. J. Natl. Cancer Inst., 92 (2000) 388–396.
5. Guillem JG, Puig-La Calle J, Akhurst T, Tickoo S, Ruo L, Minsky BD, etal. Prospective assessment of primary rectal cancer response to preoperative radiation and chemotherapy using 18-fluorodeoxyglucose positron emission tomography. Dis. Colon Rectum, 43 (2000) 18–24.